ADM and pancreatic adenocarcinoma: High ADM expression was significantly linked to poor prognosis in patients with LGG, LUAD, MESO, THYM, LIHC, HNSC, GBM, KICH, KIRP, CESC, PAAD, and STAD, with shorter OS observed in these patients.